A Multicenter, Randomized, Controlled Study to Assess Mitral vAlve reconsTrucTion for advancEd Insufficiency of Functional or iscHemic ORigiN

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 210 participants.

Also called NCT02371512

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 210 participants (planned count) (from the registry)
Sponsor
Universitätsklinikum Köln (from the registry)
Registry
  • NCT NCT02371512
Other papers using this trial's data
  • Transcatheter Repair versus Mitral-Valve Surgery for Secondary Mitral Regurgitation The New England journal of medicine, 2024-11-14 DOI, PubMed 39216093

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02371512. Randomized; no masking; primary purpose treatment. Start 2015-02 (registry gives no type); primary completion 2019-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Multicenter, Randomized, Controlled Study to Assess Mitral vAlve reconsTrucTion for advancEd Insufficiency of Functional or iscHemic ORigiN
Acronym
MATTERHORN
Condition
Mitral Valve Insufficiency
Intervention (Device)
MitraClip system (Abbott Vascular, Menlo Park, USA)
Intervention (Procedure)
Mitral valve surgery
Lead sponsor
Universitätsklinikum Köln (class: other)
Collaborator
The Clinical Trials Centre Cologne (class: other)

Record details

Record id
cardio:ct-nct02371512
Content hash
fcef5adc4c4830c0e7f4edf9809444c41f5001cf809c7529b743ba00da76773c